{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:42:19Z","timestamp":1787622139240,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.reumae.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T15:33:15Z","timestamp":1703863995000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["VEXAS syndrome: Clinical manifestations, diagnosis, and treatment"],"prefix":"10.1016","volume":"20","author":[{"given":"Michelle Patricia","family":"Loeza-Uribe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hinojosa-Azaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz E.","family":"S\u00e1nchez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Crisp\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Apodaca-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela A.","family":"Ferrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mart\u00edn-Nares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.reumae.2023.12.004_bib0005","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med."},{"issue":"26","key":"10.1016\/j.reumae.2023.12.004_bib0010","first-page":"3591","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.reumae.2023.12.004_bib0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminhematol.2022.07.003","article-title":"Somatic mutations in VEXAS Syndrome and Erdheim-Chester disease: inflammatory myeloid diseases","volume":"59","author":"Alcedo","year":"2022","journal-title":"Semin Hematol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1199\/tab.0174","article-title":"The ubiquitination machinery of the ubiquitin system","volume":"12","author":"Callis","year":"2014","journal-title":"Arabidopsis Book."},{"issue":"8","key":"10.1016\/j.reumae.2023.12.004_bib0025","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4161\/cc.19978","article-title":"Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage","volume":"11","author":"Moudry","year":"2012","journal-title":"Cell Cycle."},{"issue":"10","key":"10.1016\/j.reumae.2023.12.004_bib0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.molmed.2015.08.003","article-title":"UBA1: at the crossroads of ubiquitin homeostasis and neurodegeneration","volume":"21","author":"Groen","year":"2015","journal-title":"Trends Mol Med"},{"issue":"47","key":"10.1016\/j.reumae.2023.12.004_bib0035","doi-asserted-by":"crossref","first-page":"18337","DOI":"10.1074\/jbc.RA118.003975","article-title":"Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity","volume":"293","author":"Lv","year":"2018","journal-title":"J Biol Chem."},{"key":"10.1016\/j.reumae.2023.12.004_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/1744666X.2023.2157262","article-title":"An update on VEXAS syndrome","volume":"19","author":"Al-Hakim","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.reumae.2023.12.004_bib0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/mrcr\/rxab021","article-title":"UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review","volume":"6","author":"Shaukat","year":"2022","journal-title":"Mod Rheumatol Case Rep."},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00281-015-0496-2","article-title":"Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond","volume":"37","author":"Agyemang","year":"2015","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0055","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2018.00422","article-title":"Regulation of cytokine production by the unfolded protein response; implications for infection and autoimmunity","volume":"9","author":"Smith","year":"2018","journal-title":"Front Immunol."},{"issue":"13","key":"10.1016\/j.reumae.2023.12.004_bib0060","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2022016985","article-title":"Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis","volume":"140","author":"Ferrada","year":"2022","journal-title":"Blood."},{"issue":"26","key":"10.1016\/j.reumae.2023.12.004_bib0065","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.2020010177","article-title":"Therapeutic options in VEXAS syndrome: insights from a retrospective series","volume":"137","author":"Bourbon","year":"2021","journal-title":"Blood."},{"issue":"26","key":"10.1016\/j.reumae.2023.12.004_bib0070","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.2020010286","article-title":"Novel somatic mutations in UBA1 as a cause of VEXAS syndrome","volume":"137","author":"Poulter","year":"2021","journal-title":"Blood."},{"issue":"7","key":"10.1016\/j.reumae.2023.12.004_bib0075","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/art.42471","article-title":"Novel somatic UBA1 variant in a patient with VEXAS syndrome","volume":"75","author":"Stiburkova","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0080","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000868","article-title":"Recurrent mutations of the active adenylation domain of UBA1 in atypical form of VEXAS syndrome","volume":"7","author":"Faurel","year":"2023","journal-title":"Hemasphere."},{"issue":"11","key":"10.1016\/j.reumae.2023.12.004_bib0085","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","article-title":"UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome","volume":"157","author":"Zakine","year":"2021","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.reumae.2023.12.004_bib0090","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1093\/rheumatology\/keab866","article-title":"Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis","volume":"61","author":"Cordts","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reumae.2023.12.004_bib0095","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/ard-2023-224460","article-title":"Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism","volume":"82","author":"Mascaro","year":"2023","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jama.2022.24836","article-title":"Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population","volume":"329","author":"Beck","year":"2023","journal-title":"JAMA."},{"key":"10.1016\/j.reumae.2023.12.004_bib0105","article-title":"VEXAS syndrome \u2013 A review of pathophysiology, presentation, and prognosis","author":"Koster","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.reumae.2023.12.004_bib0110","article-title":"Challenging the paradigm: a case of early-onset VEXAS syndrome","author":"S\u00e1nchez-Hern\u00e1ndez","year":"2023","journal-title":"Rheumatology (Oxford)."},{"issue":"8","key":"10.1016\/j.reumae.2023.12.004_bib0115","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","article-title":"Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis","volume":"80","author":"Tsuchida","year":"2021","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.reumae.2023.12.004_bib0120","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol."},{"issue":"23","key":"10.1016\/j.reumae.2023.12.004_bib0125","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10235586","article-title":"USAID associated with myeloid neoplasm and VEXAS syndrome: two differential diagnoses of suspected adult onset still\u2019s disease in elderly patients","volume":"10","author":"Delplanque","year":"2021","journal-title":"J Clin Med."},{"issue":"11","key":"10.1016\/j.reumae.2023.12.004_bib0130","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1093\/rheumatology\/keab392","article-title":"VEXAS syndrome in a woman","volume":"60","author":"Barba","year":"2021","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0135","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3324\/haematol.2021.280238","article-title":"VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)","volume":"107","author":"Stubbins","year":"2022","journal-title":"Haematologica"},{"issue":"22","key":"10.1016\/j.reumae.2023.12.004_bib0140","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1056\/NEJMc2102124","article-title":"Mutant UBA1 and severe adult-onset autoinflammatory disease","volume":"384","author":"Diarra","year":"2021","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1016\/j.reumae.2023.12.004_bib0145","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1038\/s41375-021-01353-8","article-title":"Prevalence of UBA1 mutations in MDS\/CMML patients with systemic inflammatory and auto-immune disease","volume":"35","author":"Zhao","year":"2021","journal-title":"Leukemia."},{"issue":"10","key":"10.1016\/j.reumae.2023.12.004_bib0150","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3899\/jrheum.210149","article-title":"Somatic mutation in UBA1 and ANCA-associated vasculitis","volume":"48","author":"Ross","year":"2021","journal-title":"J Rheumatol."},{"issue":"10","key":"10.1016\/j.reumae.2023.12.004_bib0155","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.mayocp.2021.06.006","article-title":"Clinical heterogeneity of the VEXAS syndrome: a case series","volume":"96","author":"Koster","year":"2021","journal-title":"Mayo Clin Proc."},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0160","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.41992","article-title":"VEXAS syndrome: a case series from a single-center cohort of italian patients with vasculitis","volume":"74","author":"Muratore","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.reumae.2023.12.004_bib0165","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/rheumatology\/keab782","article-title":"VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin A vasculitis","volume":"61","author":"P\u00e0mies","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reumae.2023.12.004_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108996","article-title":"Beh\u00e7et\u2019s disease with a somatic UBA1 variant: expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome","volume":"238","author":"Matsumoto","year":"2022","journal-title":"Clin Immunol."},{"issue":"7","key":"10.1016\/j.reumae.2023.12.004_bib0175","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.7326\/L21-0023","article-title":"Severe joint involvement in VEXAS syndrome: a case report","volume":"174","author":"Lacombe","year":"2021","journal-title":"Ann Intern Med."},{"issue":"9","key":"10.1016\/j.reumae.2023.12.004_bib0180","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1093\/rheumatology\/keab211","article-title":"VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy","volume":"60","author":"Magnol","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.reumae.2023.12.004_bib0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.41957","article-title":"VEXAS syndrome with systemic lupus erythematosus: expanding the spectrum of associated conditions","volume":"74","author":"Sharma","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107245","article-title":"Pulmonary manifestations in VEXAS syndrome","volume":"213","author":"Casal Moura","year":"2023","journal-title":"Respir Med."},{"key":"10.1016\/j.reumae.2023.12.004_bib0195","first-page":"1","article-title":"Recurrent orbital inflammation associated with VEXAS syndrome","volume":"27","author":"Beecher","year":"2022","journal-title":"Orbit."},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0200","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jaad.2022.10.052","article-title":"Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a multicenter retrospective study of 59 cases","volume":"88","author":"Zakine","year":"2023","journal-title":"J Am Acad Dermatol."},{"issue":"1","key":"10.1016\/j.reumae.2023.12.004_bib0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40164-022-00262-5","article-title":"Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome","volume":"11","author":"Lacombe","year":"2022","journal-title":"Exp Hematol Oncol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0210","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.13944","article-title":"VEXAS syndrome: a review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation","author":"Cherniawsky","year":"2023","journal-title":"Eur J Haematol."},{"issue":"16","key":"10.1016\/j.reumae.2023.12.004_bib0215","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.reumae.2023.12.004_bib0220","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000775","article-title":"UBA1 screening in sweet syndrome with hematological neoplasms reveals a novel association between VEXAS and chronic myelomonocytic leukemia","volume":"6","author":"Gurnari","year":"2022","journal-title":"Hemasphere."},{"issue":"10","key":"10.1016\/j.reumae.2023.12.004_bib0225","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.reumae.2023.12.004_bib0230","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patients with VEXAS","volume":"149","author":"van der Made","year":"2022","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0235","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.medcli.2022.06.018","article-title":"Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: the VEXAS syndrome","volume":"159","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2022","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"10.1016\/j.reumae.2023.12.004_bib0240","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.chest.2022.10.011","article-title":"Pleuropulmonary manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome","volume":"163","author":"Borie","year":"2023","journal-title":"Chest."},{"key":"10.1016\/j.reumae.2023.12.004_bib0245","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002255","article-title":"Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients","volume":"8","author":"Khitri","year":"2022","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.reumae.2023.12.004_bib0250","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/art.42101","article-title":"Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series","volume":"74","author":"Campochiaro","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"22","key":"10.1016\/j.reumae.2023.12.004_bib0255","first-page":"00181","article-title":"VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist","volume":"S0190-9622","author":"Sterling","year":"2022","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0260","article-title":"Vasculitis associated with VEXAS syndrome: a literature review","volume":"9","author":"Watanabe","year":"2022","journal-title":"Front Med (Lausanne)."},{"issue":"2","key":"10.1016\/j.reumae.2023.12.004_bib0265","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/RLU.0000000000004506","article-title":"Aortitis PET imaging in VEXAS syndrome: a case report","volume":"48","author":"Grambow-Velilla","year":"2023","journal-title":"Clin Nucl Med."},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0270","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/03009742.2022.2045791","article-title":"Orbital and periorbital inflammation in VEXAS syndrome","volume":"51","author":"Mart\u00edn-Nares","year":"2022","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jdcr.2022.02.022","article-title":"Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome","volume":"23","author":"Goyal","year":"2022","journal-title":"JAAD Case Rep."},{"issue":"3","key":"10.1016\/j.reumae.2023.12.004_bib0280","article-title":"Adverse reaction to COVID-19 mRNA vaccination in a patient with VEXAS syndrome","volume":"14","author":"Ciprian","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.reumae.2023.12.004_bib0285","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/art.41775","article-title":"Extensive multiple organ involvement in VEXAS syndrome","volume":"73","author":"Takahashi","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.reumae.2023.12.004_bib0290","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1093\/rheumatology\/keac356","article-title":"Novel genetic mutation in myositis-variant of VEXAS syndrome","volume":"61","author":"Topilow","year":"2022","journal-title":"Rheumatology (Oxford)."},{"issue":"10","key":"10.1016\/j.reumae.2023.12.004_bib0295","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1093\/rheumatology\/keab349","article-title":"A case of polychondritis-onset refractory organizing pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of 7 years","volume":"60","author":"Sakuma","year":"2021","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0300","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.seminhematol.2021.10.007","article-title":"Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome","volume":"58","author":"Patel","year":"2021","journal-title":"Semin Hematol."},{"issue":"26","key":"10.1016\/j.reumae.2023.12.004_bib0305","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.2021010811","article-title":"Vacuolization of hematopoietic precursors: an enigma with multiple etiologies","volume":"137","author":"Gurnari","year":"2021","journal-title":"Blood."},{"issue":"12","key":"10.1016\/j.reumae.2023.12.004_bib0310","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1093\/rheumatology\/keab524","article-title":"Atypical splice-site mutations causing VEXAS syndrome","volume":"60","author":"Templ\u00e9","year":"2021","journal-title":"Rheumatology (Oxford)."},{"issue":"7","key":"10.1016\/j.reumae.2023.12.004_bib0315","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1007\/s10875-021-01070-y","article-title":"A case of VEXAS syndrome complicated by hemophagocytic lymphohistiocytosis","volume":"41","author":"Grey","year":"2021","journal-title":"J Clin Immunol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0320","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.seminhematol.2021.10.006","article-title":"Thrombotic manifestations of VEXAS syndrome","volume":"58","author":"Groarke","year":"2021","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0325","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.seminhematol.2021.10.001","article-title":"Genetics of somatic auto-inflammatory disorders","volume":"58","author":"Poulter","year":"2021","journal-title":"Semin Hematol."},{"issue":"2","key":"10.1016\/j.reumae.2023.12.004_bib0330","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bjh.17679","article-title":"Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold","volume":"195","author":"Lacombe","year":"2021","journal-title":"Br J Haematol."},{"issue":"4","key":"10.1016\/j.reumae.2023.12.004_bib0335","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjh.17930","article-title":"Towards treatments for VEXAS","volume":"196","author":"Patel","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.reumae.2023.12.004_bib0340","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/s41375-022-01698-8","article-title":"A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune\/inflammatory disorders and VEXAS syndrome associated with MDS and CMML","volume":"36","author":"Mekinian","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.reumae.2023.12.004_bib0345","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.seminhematol.2021.09.001","article-title":"Toward a pathophysiology inspired treatment of VEXAS syndrome","volume":"58","author":"Heiblig","year":"2021","journal-title":"Semin Hematol"},{"key":"10.1016\/j.reumae.2023.12.004_bib0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678927","article-title":"Case report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome","volume":"12","author":"Staels","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.reumae.2023.12.004_bib0355","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/annrheumdis-2021-220876","article-title":"Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan","volume":"80","author":"Kirino","year":"2021","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"10.1016\/j.reumae.2023.12.004_bib0360","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood.2022016642","article-title":"Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study","volume":"140","author":"Heiblig","year":"2022","journal-title":"Blood."},{"key":"10.1016\/j.reumae.2023.12.004_bib0365","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1097\/HS9.0000000000000661","article-title":"Azacytidine treatment for VEXAS syndrome","volume":"5","author":"Raaijmakers","year":"2021","journal-title":"Hemasphere."},{"key":"10.1016\/j.reumae.2023.12.004_bib0370","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead240","article-title":"How to treat VEXAS-Syndrome: a systematic review on effectiveness and safety of current treatment strategies","author":"Boyadzhieva","year":"2023","journal-title":"Rheumatology (Oxford)."},{"issue":"23","key":"10.1016\/j.reumae.2023.12.004_bib0375","first-page":"00231","article-title":"Autoimmune manifestations in VEXAS: opportunities for integration and pitfalls to interpretation","volume":"S0091-6749","author":"Bruno","year":"2023","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.reumae.2023.12.004_bib0380","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1182\/bloodadvances.2021004749","article-title":"Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience","volume":"6","author":"Diarra","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.reumae.2023.12.004_bib0385","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1002\/ajh.26786","article-title":"Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients","volume":"98","author":"Mangaonkar","year":"2023","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.reumae.2023.12.004_bib0390","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s10067-022-06338-1","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review","volume":"41","author":"Guerrero-Berm\u00fadez","year":"2022","journal-title":"Clin Rheumatol."}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574323001661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574323001661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:03:30Z","timestamp":1761879810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574323001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2173574323001661"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2023.12.004","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VEXAS syndrome: Clinical manifestations, diagnosis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2023.10.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}